A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL

Clinical trial NCT03467867 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03467867
Sponsor: Georgetown University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2018-04-26
Primary completion: 2026-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.